{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:25:01Z","timestamp":1782746701741,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jpba.2023.115287","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T21:00:05Z","timestamp":1675976405000},"page":"115287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Structural identification and comprehensive comparison of saponin-related impurities present in the three different compound glycyrrhizin tablets"],"prefix":"10.1016","volume":"229","author":[{"given":"Li","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Yun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Ping","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9433-8325","authenticated-orcid":false,"given":"Yun-Feng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2023.115287_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/0929867033368538","article-title":"Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine","volume":"10","author":"Baltina","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpba.2023.115287_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s11101-021-09785-x","article-title":"Immunomodulatory properties of triterpenes","volume":"21","author":"Renda","year":"2022","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.jpba.2023.115287_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jfma.2012.08.012","article-title":"Intravenous glycyrrhizin improved serum transaminases rapidly in a chronic hepatitis B patient with acute exacerbation","volume":"114","author":"Lin","year":"2015","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.jpba.2023.115287_bib4","first-page":"4560","article-title":"Efficacy observation of compound glycyrrhizin tablets combined with traditional chinese medicine in the treatment of chronic eczema","volume":"21","author":"Shen","year":"2010","journal-title":"China Pharm."},{"key":"10.1016\/j.jpba.2023.115287_bib5","first-page":"987","article-title":"Effect of compound glycyrrhizin injection by pneumatic sprayer on atopic dermatitis-like mouse model","volume":"35","author":"Zhang","year":"2021","journal-title":"Chin. J. Derm. Venereol."},{"key":"10.1016\/j.jpba.2023.115287_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eujim.2019.100975","article-title":"The clinical efficacy and safety of oral compound glycyrrhizin in adult patients with mild-to-moderate active alopecia areata: a randomized controlled study","volume":"32","author":"Qi","year":"2019","journal-title":"Eur. J. Integr. Med."},{"key":"10.1016\/j.jpba.2023.115287_bib7","first-page":"240","article-title":"Clinical trial of compound glycyrrhizin tablets in the treatment of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome","volume":"34","author":"Feng","year":"2018","journal-title":"Chin. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2023.115287_bib8","first-page":"24","article-title":"Clinical effect of ursodeoxycholic acid capsules combined with compound glycyrrhizin tablets in the treatment of steatohepatitis","volume":"15","author":"Luo","year":"2022","journal-title":"Chin. J. Clin. Ration. Drug Use"},{"key":"10.1016\/j.jpba.2023.115287_bib9","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1007\/s00216-022-04205-1","article-title":"Characterization of structurally related peptide impurities using HPLC-QTOF-MS\/MS: application to Cbf-14, a novel antimicrobial peptide","volume":"414","author":"Huo","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2023.115287_bib10","first-page":"844","article-title":"Analysis of related substances of monoammonium glycyrrhizinate by LC-MS n","volume":"40","author":"Mu","year":"2009","journal-title":"Chin. J. Pharm."},{"key":"10.1016\/j.jpba.2023.115287_bib11","first-page":"1286","article-title":"Simultaneous separation and detection of principal component isomer and related substances of raw material drug of ammonium glycyrrhizinate by RP-HPLC and structure confirmation","volume":"48","author":"Zhao","year":"2013","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.jpba.2023.115287_bib12","first-page":"1748","article-title":"Identification and characterization of the related substances of monoammonium glycyrrhizinate and its high temperature degradation by HPLC-QTOF MS\/MS and NMR","volume":"41","author":"Li","year":"2021","journal-title":"Chin. J. Pharm. Anal."},{"key":"10.1016\/j.jpba.2023.115287_bib13","unstructured":"European Pharmacopoeia 9.0, Ammonium Glycyrrhizate, (2017) 1716."},{"key":"10.1016\/j.jpba.2023.115287_bib14","unstructured":"United States Pharmacopoeia 42-NF37, Ammonium Glycyrrhizate, (2019) 5573."},{"key":"10.1016\/j.jpba.2023.115287_bib15","first-page":"324","article-title":"Study on new process for the production and purification of monoammonium glycyrrhizinate","volume":"32","author":"Shi","year":"2011","journal-title":"Sci. Technol. Food Ind."},{"key":"10.1016\/j.jpba.2023.115287_bib16","first-page":"125","article-title":"Orthogonal array design for the optimization of monoammonium glycyrrhizinate purification by activated carbon adsorption-ethanol recrystallization","volume":"34","author":"Shi","year":"2013","journal-title":"Food Sci."},{"key":"10.1016\/j.jpba.2023.115287_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.foodchem.2017.07.106","article-title":"A comparative UPLC-Q\/TOF-MS-based metabolomics approach for distinguishing Zingiber officinale Roscoe of two geographical origins","volume":"240","author":"Mais","year":"2018","journal-title":"Food Chem."},{"key":"10.1016\/j.jpba.2023.115287_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1248\/cpb.41.43","article-title":"Saponin and sapogenol. XLVII. On the constituents of the roots of Glycyrrhiza uralensis Fischer from northeastern China. (1). Licorice-saponins A3, B2, and C2","volume":"41","author":"Kitagawa","year":"1993","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jpba.2023.115287_bib19","first-page":"663","article-title":"Spectral Characteristics and Structure Identification of Principal Components and Related Substances in Bulk Drug of Ammonium Glycyrrhizate","volume":"45","author":"Zhao","year":"2014","journal-title":"Chin. J. Pharm."},{"key":"10.1016\/j.jpba.2023.115287_bib20","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.3390\/molecules20046273","article-title":"Hepatoprotective triterpene saponins from the roots of Glycyrrhiza inflata","volume":"20","author":"Zheng","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2023.115287_bib21","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1021\/np500253m","article-title":"Uralsaponins M\u2013Y, antiviral triterpenoid saponins from the roots of Glycyrrhiza uralensis","volume":"77","author":"Song","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.jpba.2023.115287_bib22","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1021\/acs.jnatprod.8b00022","article-title":"Saponins from European licorice roots (Glycyrrhiza glabra)","volume":"81","author":"Schmid","year":"2018","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.jpba.2023.115287_bib23","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1002\/rcm.4768","article-title":"Structural characterization and identification of oleanane-type triterpene saponins in Glycyrrhiza uralensis Fischer by rapid-resolution liquid chromatography coupled with time-of-flight mass spectrometry","volume":"24","author":"Zheng","year":"2010","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2023.115287_bib24","doi-asserted-by":"crossref","first-page":"14684","DOI":"10.1021\/acs.jafc.0c05407","article-title":"Comprehensive comparison of two color varieties of perillae folium using rapid resolution liquid chromatography coupled with quadruple-time-of-flight mass spectrometry (RRLC-Q\/TOF-MS)-based metabolic profile and in vivo\/in vitro anti-oxidative activity","volume":"68","author":"Zheng","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jpba.2023.115287_bib25","unstructured":"ICH, Q3(R2)\/Impurities inNew Drug Substances, 2006."},{"key":"10.1016\/j.jpba.2023.115287_bib26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.taap.2013.04.012","article-title":"Genotoxicity of 2-bromo-3\u2032-chloropropiophenone","volume":"270","author":"Meng","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523000560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523000560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:26:46Z","timestamp":1760002006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523000560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":26,"alternative-id":["S0731708523000560"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115287","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural identification and comprehensive comparison of saponin-related impurities present in the three different compound glycyrrhizin tablets","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115287"}}